viral
infect
human
papillomavirus
hpv
caus
benign
wart
malign
tumor
small
nonenvelop
viru
constitut
circular
dna
genom
surround
capsid
mainli
built
protein
papillomaviru
type
character
divers
host
includ
mammal
bird
reptil
instanc
oncogen
hpv
type
respons
sever
human
cancer
includ
cervic
cancer
anogenit
head
neck
tumor
doorbar
et
al
hpv
infect
requir
microwound
enabl
virion
bind
mitot
activ
basal
keratinocyt
doorbar
et
al
ozbun
howev
viru
intern
asynchron
slow
halftim
sever
hour
sapp
bienkowskahaba
becker
et
al
schelhaa
et
al
long
halftim
point
toward
complex
cascad
event
cell
membran
prior
viru
entri
host
cell
assum
sequenc
initi
upon
viru
bind
primari
receptor
viru
releas
modifi
form
follow
rebind
secondari
receptor
complex
endocytos
ozbun
raff
et
al
florin
date
requir
viru
associ
secondari
entri
receptor
composit
receptor
complex
well
understood
one
main
compon
tetraspanin
local
cell
surfac
enrich
domain
associ
particl
spoden
et
al
scheffer
et
al
essenti
viral
endocytosi
spoden
et
al
scheffer
et
al
spoden
et
al
scheffer
et
al
fast
et
al
cointern
viru
via
clathrin
caveolin
dynaminindepend
endocyt
pathway
spoden
et
al
spoden
et
al
integrin
complex
scheffer
et
al
evand
et
al
mcmillan
et
al
annexin
heterotetram
woodham
et
al
dziduszko
ozbun
cytoskelet
adaptor
obscurinlik
one
protein
et
al
tetraspanin
spoden
et
al
compon
entri
receptor
complex
addit
growth
factor
receptor
gfr
particular
epiderm
growth
factor
receptor
egfr
propos
entri
receptor
surviladz
et
al
multipl
virus
vaccinia
cytomegalo
herp
simplex
influenza
hepat
c
viru
et
al
moreov
signal
transduct
like
activ
egfr
erk
signal
prerequisit
hpv
infect
schelhaa
et
al
surviladz
et
al
activ
signal
pathway
indic
cell
defin
activ
state
suscept
infect
type
molecul
may
trigger
state
link
signal
entri
complex
recent
data
indic
metalloproteas
involv
earli
infect
surviladz
et
al
mani
known
metalloproteas
member
disintegrin
metalloproteas
adam
famili
regul
multipl
cell
signal
pathway
releas
bioactiv
protein
like
gfr
ligand
gooz
sahin
et
al
horiuchi
et
al
therebi
adam
may
repres
connect
cell
signal
compon
viral
entri
complex
set
studi
adam
famili
member
may
play
role
may
regul
cascad
infect
pathway
recent
suggest
metalloproteas
mediat
earli
step
infect
surviladz
et
al
studi
broadspectrum
inhibitor
differenti
matrix
metalloproteinas
mmp
adam
parvathi
et
al
mustafi
et
al
amour
et
al
de
meijer
et
al
rasmussen
mccann
murphi
adam
famili
like
candid
highli
express
keratinocyt
lee
et
al
maretzki
et
al
sommer
et
al
brook
et
al
hirayama
et
al
involv
shed
numer
substrat
reiss
saftig
edward
et
al
infect
hacat
keratinocyt
pseudovirion
psv
appli
broadspectrum
metalloproteinas
inhibitor
preferenti
inhibitor
gi
mix
inhibitor
gw
figur
supplement
gw
diminish
infect
wherea
inhibitor
gi
show
signific
effect
point
toward
requir
adam
particular
rather
differenti
two
adam
specif
approach
deplet
sirna
knockdown
respect
two
differ
sirna
employ
three
epitheli
cell
model
includ
hela
cell
hacat
cell
primari
normal
human
epitheli
keratinocyt
nhek
condit
deplet
consist
strongli
decreas
infect
figur
contrast
deplet
show
clear
effect
figur
supplement
also
requir
infect
two
highli
oncogen
hpv
type
figur
altogeth
indic
import
infect
oncogen
human
papillomavirus
tetraspanin
defin
entri
receptor
complex
scheffer
et
al
scheffer
et
al
therefor
ask
whether
requir
associ
prior
test
role
character
time
cours
viru
coloc
entri
receptor
compon
hacat
incub
psv
min
wash
fix
incub
sever
hour
prior
fixat
directli
viru
incub
mark
time
point
found
viru
particl
associ
cell
surfac
poorli
overlap
domain
figur
supplement
one
hour
ad
psv
correspond
time
point
moder
increas
overlap
increas
next
hr
appar
plateau
hr
figur
supplement
line
previou
time
cours
analys
interact
hela
cell
spoden
et
al
slow
associ
viral
particl
domain
impli
idea
slowli
matur
entri
platform
learn
process
analyz
domain
employ
nanoscopi
previous
done
tetraspanin
homsi
et
al
zuidscherwoud
et
al
superresolut
sted
microscopi
reveal
defin
nanoclust
pattern
suggest
larger
domain
record
diffractionlimit
microscopi
fact
close
associ
nanoclust
resolv
nanoclust
pattern
enabl
us
determin
distanc
bound
viral
particl
next
nearest
nanoclust
figur
averag
size
cluster
roughli
nm
see
figur
hpv
particl
size
nm
baker
et
al
therefor
distanc
shorter
nm
allow
physic
contact
viral
particl
nanoclust
interestingli
uncov
larg
fraction
psv
close
proxim
nanoclust
alreadi
directli
viru
bind
fraction
close
associ
viral
particl
strongli
increas
time
figur
b
exclud
underestim
increas
fraction
due
preferenti
intern
tight
particl
associ
importantli
well
bright
site
viral
particl
bind
increas
figur
suggest
viral
particl
enrich
prepar
endocytosi
enrich
viral
particl
bind
site
due
viral
particl
move
toward
cluster
stationari
viral
particl
trap
mix
scenario
tirf
microscopi
studi
dynam
viral
particl
viral
particl
clearli
immobil
move
fast
figur
supplement
observ
line
previou
report
show
psv
confin
cell
bodi
schelhaa
et
al
tetraspanin
cluster
stabl
second
homsi
et
al
exclud
track
studi
diffract
limit
microscopi
well
resolv
individu
nanoclust
monitor
larger
intracellular
vesicl
howev
viral
particl
stationari
tetraspanin
mobil
espenel
et
al
platform
matur
presum
involv
nucleat
viral
particl
bind
site
increas
intens
psv
bind
site
figur
illustr
slow
process
take
sever
hour
next
test
whether
play
role
associ
viral
particl
domain
two
differ
epitheli
cell
line
hr
initi
psv
contact
found
signific
effect
deplet
reduc
overlap
roughli
third
hacat
nhek
figur
data
reveal
spatial
proxim
viru
still
possibl
viral
particl
domain
although
overlap
micrograph
exhibit
distanc
nm
physic
interact
corrobor
spatial
proxim
better
resolut
turn
duolink
proxim
ligat
assay
pla
fredriksson
et
al
et
al
pla
bright
fluoresc
spot
form
site
two
differ
molecular
entiti
closer
nm
bagchi
et
al
mendez
banerje
henc
assay
fluoresc
spot
indic
site
viral
particl
domain
inde
close
enough
interact
physic
pla
found
pla
signal
strongli
depend
figur
h
thu
microscop
analysi
pla
suggest
mediat
close
associ
hpv
domain
mean
either
requir
initi
viru
bind
play
role
somewher
bind
endocyt
platform
format
exampl
cleavageprim
anoth
proteas
investig
role
viru
bind
employ
flow
cytometri
analysi
test
whether
deplet
diminish
number
psv
cell
surfac
case
figur
supplement
therefor
exclud
requir
initi
viru
bind
cell
surfac
investig
activ
use
posit
control
cleavag
pattern
viral
protein
prime
find
neither
substrat
figur
supplement
b
intern
viral
particl
effici
inhibit
deplet
figur
supplement
instead
cleavag
product
substanti
decreas
cell
figur
supplement
f
therefor
specul
activ
requir
viral
particl
associ
proteas
prior
endocytosi
addit
proteas
intracellular
compart
infecti
entri
pathway
cerqueira
et
al
inhibit
earli
step
plasma
membran
rather
lead
viru
intern
noninfecti
entri
pathway
describ
earlier
selinka
et
al
growth
factor
receptor
like
egfr
propos
addit
compon
entri
receptor
complex
surviladz
et
al
anticip
hacat
cell
find
microscop
overlap
egfr
figur
significantli
diminish
absenc
figur
b
next
employ
fluoresc
microscopi
imagedeconvolut
studi
doubl
stain
egfr
figur
similar
egfr
local
pattern
indic
coenrich
two
membran
protein
moreov
superresolut
sted
microscopi
quantit
analysi
thereof
reveal
overlap
tetraspanin
egfr
figur
e
line
previou
report
demonstr
growth
factor
receptor
recruit
tetraspaninenrich
microdomain
berditchevski
odintsova
zona
et
al
bruen
et
al
howev
overlap
independ
figur
conclus
indic
requir
associ
secondari
entri
receptor
complex
compos
preform
nanoclust
assembl
investig
possibl
chang
cluster
viru
infect
treat
hacat
cell
psv
hr
analyz
sted
microscopi
immunostain
pattern
membran
sheet
gener
prior
fixat
homsi
et
al
treatment
ensur
structur
locat
plasma
membran
analyz
figur
supplement
find
domain
psvsnonexpos
cell
averag
size
nm
figur
often
sever
individu
cluster
gather
togeth
group
figur
psv
reduc
cluster
diamet
nm
accompani
reduct
overal
stain
intens
figur
c
reduct
plasma
membran
level
viral
uptak
expect
cointern
viral
particl
scheffer
et
al
reduct
cluster
diamet
level
requir
figur
c
henc
data
indic
presenc
entiti
effici
endocytos
reduct
nm
may
suggest
modest
differ
size
howev
reduct
cluster
diamet
quarter
correspond
halv
area
moreov
reduct
diamet
conjunct
diminish
level
suggest
preferenti
intern
larger
cluster
thu
viral
particl
induc
endocyt
uptak
twofold
larger
averag
platform
viru
particl
signal
molecul
could
bind
back
cell
releas
diffus
toward
distal
cell
figur
follow
examin
whether
sheddas
activ
requir
releas
viru
particl
primari
bind
site
altern
whether
produc
bioactiv
compound
like
signal
molecul
requir
platform
matur
studi
question
differenti
two
step
releas
rebind
use
cocultur
transwel
assay
figur
experiment
setup
restrain
direct
celltocel
contact
allow
exchang
solubl
compound
like
virus
bioactiv
molecul
exampl
growth
factor
gf
donor
recipi
cell
assay
cell
releas
substanc
call
donor
cell
donor
cultur
insert
recipi
cell
recipi
place
chamber
thu
abl
receiv
substanc
releas
donor
previous
shown
donor
cell
support
infect
recipi
cell
surviladz
et
al
assay
control
donor
hacat
cell
incub
psv
hr
intens
wash
remov
unbound
viru
place
recipi
cell
next
day
assay
infect
expect
deplet
donor
cell
strongli
diminish
infect
also
halv
infect
recipi
cell
figur
demonstr
viru
particl
releas
donor
cell
diffus
recipi
cell
howev
sever
possibl
explan
lower
infect
rate
recipi
cell
recipi
receiv
less
viru
particl
ii
amount
less
infecti
particl
iii
less
bioactiv
molecul
requir
signal
pathway
activ
clarif
examin
whether
quantiti
protein
supernat
indic
releas
viral
particl
found
differ
control
cell
figur
suggest
releas
viru
particl
primari
attach
receptor
requir
line
previou
find
quantiti
surfac
bound
viru
particl
shown
figur
supplement
thu
differ
releas
exclud
possibl
recipi
cell
receiv
less
viru
particl
viru
particl
less
infecti
releas
cell
test
cocultur
assay
perform
invert
condit
nontreat
donor
cell
incub
psv
ensur
releas
ident
viru
particl
control
recipi
cell
case
releas
viral
particl
requir
infecti
deplet
recipi
cell
effect
infect
rate
howev
observ
opposit
infect
recipi
cell
almost
complet
block
figur
lower
panel
therefor
involv
releas
solubl
bioactiv
compound
exampl
growth
factor
activ
specif
signal
pathway
infect
also
decor
viru
surviladz
et
al
might
explain
find
henc
bioactiv
molecul
requir
viral
infect
matter
whether
viral
particl
releas
rebind
cell
hypothesi
involv
releas
growth
factor
support
observ
donor
cell
invert
assay
configur
significantli
less
infect
correspond
recipi
cell
figur
upper
panel
contrast
onedirect
diffus
viru
particl
bioactiv
compound
exchang
direct
mean
donor
cell
sens
less
bioactiv
compound
recipi
cell
howev
effect
small
suggest
biomolecul
rather
act
local
diffus
larg
distanc
specul
although
viral
particl
releas
rel
fast
rebind
cell
surfac
receptor
explain
larg
fraction
viru
particl
bind
close
cluster
alreadi
min
figur
may
type
releas
biomolecul
signal
pathway
literatur
suggest
link
infect
pathway
regul
via
mitogenactiv
protein
kinas
mapk
signal
pathway
infect
requir
activ
erk
signal
via
egfr
surviladz
et
al
mediat
cleavag
growth
factor
activ
kansra
et
al
et
al
sommer
et
al
thu
use
egfr
blockingantibodi
cetuximab
confirm
function
requir
egfr
psv
infect
figur
next
test
whether
requir
phosphoryl
system
figur
c
figur
supplement
b
found
hacat
cell
deplet
reduc
phosphoryl
independ
treatment
psv
solidifi
hypothesi
act
via
erk
signal
pathway
infect
entri
platform
format
restor
erk
activ
addit
recombin
solubl
form
epiderm
growth
factor
egf
one
egfractiv
ligand
suppli
medium
egf
abolish
diminish
erk
phosphoryl
deplet
figur
b
well
restor
infect
cell
figur
moreov
egf
recov
diminish
pla
signal
cell
figur
f
find
show
solubl
biomolecul
activ
signal
pathway
prerequisit
entri
platform
format
infect
uncov
ident
specif
substrat
unambigu
link
sheddas
erk
signal
pathway
viru
infect
analyz
releas
amphiregulin
areg
transform
growth
factor
alpha
heparinbind
egflik
growth
factor
hbegf
supernat
hacat
cell
function
requir
infect
figur
proform
gf
wellknown
human
substrat
gooz
sahin
et
al
horiuchi
et
al
areg
significantli
reduc
supernat
cell
figur
b
hbegf
undetect
shown
moreov
infect
analys
show
infect
rate
significantli
reduc
areg
neutral
antibodi
ad
cell
hr
psv
addit
figur
data
verifi
role
releas
areg
indic
role
growth
factor
psv
infect
final
mimick
activ
cell
ad
cleavag
product
hbegf
areg
figur
suppli
medium
gf
restor
erk
phosphoryl
moreov
gf
treatment
increas
infect
rate
absenc
well
presenc
concentrationdepend
manner
figur
g
benefici
effect
infect
rate
observ
cell
grown
starvat
condit
medium
without
fc
presenc
figur
absenc
figur
infect
support
addit
gf
cell
treat
control
sirna
full
medium
contain
fc
figur
supplement
support
cell
figur
supplement
find
show
shed
solubl
biomolecul
like
hbegf
areg
lead
activ
signal
pathway
success
infect
conclus
cell
function
cell
neighborhood
cell
suscept
infect
mediat
cleavag
membranebound
growth
factor
precursor
specif
growth
factor
instead
act
releas
subset
differ
gf
gf
activ
erk
signal
pathway
precondit
matur
viral
particlecarri
cluster
function
entri
platform
hpv
infect
follow
cascad
event
includ
initi
viru
interact
primari
receptor
follow
modif
viral
capsid
viru
associ
secondari
entri
receptor
complex
secondari
entri
receptor
complex
enabl
endocyt
uptak
infecti
intracellular
pathway
raff
et
al
campo
mechan
underli
format
secondari
entri
receptor
complex
unknown
instanc
unclear
trigger
assembl
secondari
entri
receptor
complex
contain
egfr
function
compon
florin
examin
nanoscal
resolut
secondari
entri
receptor
complex
compon
briefli
bind
find
viral
particl
associ
cluster
next
hour
enrich
viru
bind
site
viral
particl
almost
immobil
attach
cell
bodi
intens
investig
discuss
schelhaa
et
al
suggest
recruit
viru
bind
site
presenc
psv
trigger
intern
preferenti
larger
cluster
besid
proxim
ligat
assay
show
close
associ
viral
particl
contrast
neither
affect
viru
bind
cell
surfac
influenc
releas
protein
possibl
larg
fraction
viral
particl
releas
cell
surfac
expect
primari
receptorsecondari
receptor
model
remain
close
proxim
initi
bind
site
togeth
find
suggest
psv
bind
cell
bodi
take
sever
hour
recruit
cluster
matur
function
viru
entri
platform
apart
like
compon
enrich
viral
bind
site
well
possibl
gfgfrcomplex
integrin
annexin
actin
endocytosi
cocultur
transwel
assay
modifi
viral
particl
transfer
donor
cell
recipi
cell
contrast
bioactiv
molecul
like
growth
factor
exchang
direct
cocultur
assay
provid
coupl
import
observ
first
act
viru
primari
bindingreleas
infect
almost
block
recipi
cell
receiv
viral
particl
control
donor
cell
second
observ
donor
cell
infect
lesser
extent
respect
recipi
cell
parallel
control
donor
cell
less
infect
recipi
cell
mutual
influenc
explain
exchang
bioactiv
molecul
donor
recipi
cell
direct
associ
bioactiv
molecul
viral
capsid
propos
ozbun
group
surviladz
et
al
may
increas
effect
consist
addit
find
point
toward
involv
egfr
receptor
mediat
action
biomolecul
exampl
egf
increas
infect
rate
cell
egf
increas
proxim
knockdown
knockdown
diminish
overlap
egfr
howev
egf
classic
gener
action
sahin
et
al
horiuchi
et
al
therefor
test
involv
addit
egfr
ligand
gener
ectodomain
shed
find
less
areg
supernat
cell
corrobor
reduct
infect
rate
treatment
areg
neutral
antibodi
ad
cleavag
product
areg
hbegf
supernat
serumstarv
cell
increas
phosphoryl
infect
effect
egfr
areg
inhibit
much
lower
sirna
therefor
assum
activ
egfr
also
addit
gfr
togeth
result
provid
link
gfshed
activ
signal
pathway
infect
hypothesi
combin
previous
report
observ
activ
regul
multipl
cell
signal
pathway
releas
bioactiv
protein
like
egfr
ligand
gooz
sahin
et
al
et
al
cell
signal
play
role
earli
event
entri
schelhaa
et
al
surviladz
et
al
surviladz
et
al
abban
menes
line
result
shown
ozbun
group
particl
associ
gf
like
areg
hbegf
form
infecti
complex
abl
bind
entri
receptor
surviladz
et
al
surviladz
et
al
due
plethora
substrat
gooz
reiss
saftig
edward
et
al
complex
crosstalk
signal
pathway
also
shed
addit
membranebound
precursor
cleavag
integr
membran
protein
might
involv
scenario
cointern
viral
particl
viru
endocytosi
scheffer
et
al
mechan
suppos
decreas
content
plasma
membran
accordingli
observ
reduct
level
plasma
membran
presenc
psv
furthermor
observ
cleavag
protein
describ
cleavag
occur
action
specif
proteas
cell
surfac
intern
via
infecti
entri
pathway
cerqueira
et
al
howev
find
suggest
direct
effect
extra
intracellular
process
viru
particl
viru
intern
instead
affect
cleavag
consequ
viru
intern
noninfecti
pathway
reduc
capsid
interact
proteas
resid
within
entri
platform
complex
endosom
pathway
thu
mediat
viru
associ
function
hpvendocyt
platform
enabl
host
cell
entri
via
infecti
pathway
consist
idea
entri
platform
contain
egfr
surviladz
et
al
show
signific
reduct
associ
upon
deplet
agreement
recent
shown
egfr
act
cofactor
hcv
entri
promot
specif
tetraspanin
interact
protein
result
assembl
hcv
entri
receptor
complex
zona
et
al
bruen
et
al
point
toward
gener
scheme
viral
uptak
independ
viru
structur
support
notion
tetraspanin
stand
essenti
compon
entri
receptor
complex
corona
influenza
hepat
c
virus
zona
et
al
earnest
et
al
fast
et
al
florin
lang
propos
model
gfgfr
complex
format
gfrmediat
erk
signal
prerequisit
format
virusassoci
tetraspanin
entri
platform
mani
type
virus
seem
plausibl
gfrdimer
trigger
interact
growth
factor
cognat
receptor
induc
local
accumul
associ
tetraspanin
includ
thu
cluster
cell
factor
might
explain
twofold
increas
microdomain
size
intern
virusassoci
entri
platform
furthermor
tetraspanin
regul
integrin
activ
influenc
posit
within
tetraspaninenrich
microdomain
berditchevski
et
al
stipp
yang
et
al
crowd
site
viru
particl
bound
result
coaccumul
addit
viru
interact
molecul
laminin
integrin
complex
line
previou
analysi
mutant
demonstr
import
complex
format
infect
scheffer
et
al
furthermor
membraneassoci
protein
annexin
identifi
virusgfr
complex
util
mani
virus
cell
entri
includ
florin
dziduszko
ozbun
taylor
et
al
summari
much
work
done
unveil
process
human
papillomaviru
entri
although
puzzl
process
divers
host
cell
factor
mani
step
propos
far
precis
descript
still
remain
controversi
order
deepen
understand
earli
step
infect
investig
requir
entri
platform
format
propos
model
act
shed
growth
factor
molecul
trigger
erk
signal
activ
therebi
mediat
coclust
preform
larger
microdomain
plasma
membran
event
lead
assembl
function
viru
entri
platform
prime
hpv
capsid
protein
endocytosi
infecti
pathway
eventu
infect
mous
monoclon
antibodi
mab
well
rabbit
polyclon
antibodi
pab
previous
describ
knapp
et
al
rommel
et
al
sapp
et
al
rabbit
pab
purchas
merck
millipor
darmstadt
germani
specif
mous
mab
sigmaaldrich
st
loui
mo
mous
mab
obtain
biorad
munich
germani
rabbit
monoclon
antibodi
specif
egfr
total
mapk
clone
phosphoryl
erk
mapk
clone
obtain
cell
signal
leiden
netherland
horseradish
peroxidasecoupl
hrp
pod
secondari
antibodi
immunoblot
purchas
jackson
immunoresearch
europ
ltd
cambridgeshir
uk
secondari
antibodi
immunofluoresc
detect
zeiss
axiovert
microscop
goatderiv
alexa
fluor
antibodi
sted
analys
donkey
antirabbit
alexa
fluor
cat
donkey
antimous
alexa
fluor
cat
molecular
probe
invitrogen
carlsbad
ca
neutral
antibodi
egfr
cetuximab
purchas
merck
control
mous
igg
antibodi
cat
sigmaaldrich
human
amphiregulin
cat
transform
growth
factor
cat
purchas
r
system
minneapoli
mn
canada
cyan
fluoresc
protein
cfp
tag
gener
isol
gene
bspei
xmai
insert
clontech
scheffer
et
al
ap
alkalin
phosphatas
tag
provid
dr
carl
p
blobel
horiuchi
et
al
pseudovirus
psv
prepar
previous
describ
buck
et
al
short
express
plasmid
carri
codonoptim
express
vector
cotransfect
pcdna
luciferas
report
plasmid
schneider
et
al
hek
cell
bund
et
al
spoden
et
al
mock
prepar
prepar
parallel
psv
prepar
except
hek
cell
transfect
luciferas
report
plasmid
hek
human
embryon
kidney
cell
line
cell
provid
chri
buck
bethesda
md
buck
et
al
buck
et
al
hr
transfect
cell
lyse
pseudovirus
purifi
cell
lysat
use
optiprep
sigmaaldrich
gradient
centrifug
quantif
luciferas
posit
psv
perform
describ
scheffer
et
al
bund
et
al
psv
label
psv
incub
molar
excess
alexa
fluor
succinimidylest
major
capsid
protein
hr
room
temperatur
describ
previous
scheffer
et
al
schelhaa
et
al
psv
separ
label
reagent
sizeexclus
chromatographi
use
column
ge
healthcar
chicago
il
human
cervic
carcinoma
cell
line
hela
obtain
german
resourc
center
biolog
materi
dsmz
braunschweig
germani
human
immort
keratinocyt
hacat
purchas
cell
line
servic
cl
eppelheim
germani
cell
grown
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
glutamax
invitrogen
fetal
calf
serum
fc
biochrom
ag
berlin
germani
eagl
minimum
essenti
medium
mem
nonessenti
amino
acid
ge
healthcar
antibiot
freseniu
kabi
bad
homburg
vor
der
hoeh
germani
experi
cell
grown
absenc
antibiot
dmem
supplement
glutamax
either
without
fc
cell
line
authent
use
short
tandem
repeat
str
analysi
microsynth
lindau
germani
cell
line
test
neg
mycoplasma
mycoalert
plu
mycoplasma
detect
kit
lonza
koeln
germani
microsynth
realtim
pcr
analysi
microsynth
lindau
germani
normal
human
epiderm
keratinocyt
nhek
purchas
promocel
heidelberg
germani
cultiv
accord
manufactur
instruct
follow
sirna
obtain
invitrogen
ggaagcugaccugguuacaacucau
ccagggagggaaauaugucauguau
pool
mixtur
equal
amount
sirna
allstar
neg
control
sirna
use
nonsilenc
control
obtain
qiagen
hilden
germani
follow
sirna
obtain
sigmaaldrich
ggacaaacuuaacaacaau
uacaccagucaucugguauuuccuc
cell
transfect
nm
sirna
hr
use
lipofectamin
rnaimax
invitrogen
accord
manufactur
instruct
pseudoviru
infect
assay
perform
describ
previous
spoden
et
al
briefli
hela
hacat
nhek
cell
transfect
control
adamspecif
sirna
hr
cell
expos
nhek
viral
genom
equival
vge
psv
hr
post
infect
cell
lyse
luciferas
activ
use
luciferas
substrat
buffer
mm
coenzym
mm
luciferin
mm
atp
edta
dtt
trishcl
ph
gene
transduct
effici
measur
normal
lactat
dehydrogenas
ldh
measur
cytotoxon
homogen
membran
integr
assay
promega
fitchburg
luciferas
ldh
activ
measur
tristar
lb
luminomet
berthold
technolog
bad
wildbad
germani
inhibit
studi
hacat
cell
pretreat
specifi
inhibitor
hr
psv
addit
use
metalloproteinas
collagenas
gelatinas
inhibitor
sigmaaldrich
gi
potent
inhibitor
sommer
et
al
ludwig
et
al
tocri
bioscienc
bristol
uk
hydroxamatebas
gw
inhibitor
mix
suppressor
sommer
et
al
ludwig
et
al
aobiou
gloucest
infect
rate
assess
hr
later
control
cell
treat
dimethyl
sulfoxid
carl
roth
karlsruh
germani
infect
assay
use
epiderm
growth
factor
egfalexa
fluor
complex
thermo
fischer
scientif
waltham
pretreat
cell
egf
ngml
hr
prior
addit
viru
neutral
experi
human
egfr
areg
cell
incub
medium
fc
pretreat
specif
neutral
antibodi
hr
follow
infect
psv
addit
hr
recoveri
studi
growth
factor
hacat
cell
either
starv
medium
without
fc
hr
pretreat
human
hbegf
cat
roch
cat
biolegend
koblenz
germani
areg
cat
peprotech
hamburg
deutschland
min
infect
psv
anoth
hr
cultur
medium
fc
treat
specifi
growth
factor
min
follow
infect
psv
hela
hacat
cell
transfect
either
control
luciferas
sirna
one
day
later
cell
transfect
luciferas
express
plasmid
invitrogen
hr
later
analyz
luciferas
signal
luciferas
sirna
follow
sequenc
cttacgctgagtacttcgadt
use
posit
control
sigmaaldrich
hacat
cell
transfect
control
sirna
hr
analyz
viruscellbind
effici
cell
subsequ
incub
vge
psv
hr
extens
wash
pb
remov
unbound
viru
detach
mm
edta
surfacebound
particl
stain
polyclon
antibodi
fcspb
min
follow
stain
secondari
antibodi
antirabbit
alexa
fluor
fcspb
min
amount
surfac
particl
valid
use
facscan
flow
cytomet
softwar
becton
dickinson
east
rutherford
nj
usa
describ
scheffer
et
al
et
al
hacat
cell
transfect
either
control
sirna
pool
hr
cell
incub
vge
min
next
cell
wash
icecold
fc
incub
fresh
medium
hr
afterward
supernat
transfer
silicon
tube
sampl
centrifug
transfer
fresh
tube
protein
precipit
overnight
use
aceton
next
day
sampl
lyse
sd
sampl
buffer
analyz
western
blot
detect
major
capsid
viral
protein
hacat
cell
wash
phosphatebuff
salin
pb
lyse
sodium
dodecyl
sulfat
sd
sampl
buffer
mm
trishcl
glycerin
sd
denatur
sampl
electrotransf
onto
nitrocellulos
membran
ge
healthcar
block
milk
powder
pb
afterward
membran
incub
primari
antibodi
overnight
next
day
wash
pbst
phosphatebuff
salin
contain
stain
horseradish
peroxidas
hrp
conjug
secondari
antibodi
detect
carri
use
western
lightn
plu
ecl
detect
reagent
perkinelm
waltham
signal
record
scientif
imag
super
rxn
film
fujifilm
tokio
japan
erk
protein
cell
lyse
lysi
buffer
contain
mm
trishcl
ph
mm
egta
mm
sucros
triton
analys
lysi
buffer
supplement
complet
proteas
inhibitor
cocktail
roch
penzberg
germani
mm
monohydr
prevent
adam
autocleavag
et
al
erk
studi
addit
phosphatas
inhibitor
cocktail
phosstop
roch
cell
lyse
appli
three
freezethaw
cycl
freez
thaw
denatur
min
sd
sampl
buffer
equal
amount
protein
load
gel
sampl
electrotransf
either
onto
polyvinyliden
difluorid
hybondp
ge
healthcar
nitrocellulos
membran
block
milk
powder
trisbuff
salin
tb
incub
primari
antibodi
protein
detect
use
either
pod
hrpconjug
secondari
antibodi
detect
carri
use
amersham
ecl
detect
system
ge
healthcar
western
lightn
plu
ecl
detect
reagent
perkinelm
signal
record
either
luminesc
imag
analyz
fusion
imag
system
peqlab
biotechnologi
erlangen
germani
scientif
imag
xray
film
western
blot
detect
super
rxn
fujifilm
duesseldorf
germani
hacat
cell
transfect
control
sirna
sirna
pool
hr
afterward
cell
incub
vge
hr
wash
medium
supplement
fc
incub
anoth
hr
subsequ
cell
wash
pb
lyse
sodium
dodecyl
sulfat
sd
sampl
buffer
denatur
condit
experi
recombin
human
protein
cat
r
system
use
hacat
incub
vge
posit
control
proteolyt
product
parallel
prepar
mixtur
psv
assay
buffer
recommend
optim
protein
activ
mm
tri
ph
follow
manufactur
recommend
hr
later
cell
mixtur
directli
lyse
sd
sampl
buffer
proteolyt
process
analyz
western
blot
proteinas
k
protect
assay
perform
describ
previous
et
al
miln
et
al
brief
hacat
cell
transfect
control
sirna
pool
two
differ
sirna
hr
cell
infect
vge
hr
wash
two
time
medium
supplement
fc
without
antibiot
incub
anoth
hr
afterward
hacat
wash
two
time
pb
incub
dmem
without
fc
antibiot
supplement
proteinas
k
sigmaaldrich
min
order
degrad
viral
particl
still
present
cell
surfac
control
cell
treat
cell
cultur
medium
alon
digest
stop
addit
mm
phenylmethylsulfonyl
fluorid
pmsf
subsequ
cell
wash
pb
lyze
sd
sampl
buffer
process
western
blot
cytohalasin
cytod
use
control
block
viru
entri
cytod
prevent
endocytosi
inhibit
actin
polymer
test
effect
deplet
releas
human
amphiregulin
areg
hacat
cell
transfect
control
sirna
two
day
later
medium
exchang
medium
without
fc
hr
later
supernat
collect
centrifug
g
min
supplement
complet
proteas
inhibitor
cocktail
process
analysi
sampl
test
human
amphiregulin
duoset
elisa
kit
r
system
accord
manufactur
instruct
substrat
solut
bm
blue
pod
substrat
roch
appli
measur
perform
nm
correct
wavelength
nm
ectodomain
shed
assay
shed
assay
detail
describ
previous
inou
et
al
inou
et
al
brief
hela
cell
transfect
sirna
hr
assay
order
decreas
intrins
level
one
day
sirna
transfect
hela
cell
transfect
plasmid
use
polyethylenimin
pei
sigmaaldrich
hr
medium
replac
fresh
dmem
without
fc
cell
either
expos
protein
left
nontreat
incub
hr
supernat
collect
cell
lyse
lysi
buffer
contain
mm
mm
edta
triton
water
phenanthrolin
shown
metalloproteas
inhibitor
catalysi
et
al
experi
chang
ap
activ
correl
activ
respons
shed
membranebound
ap
activ
assess
administr
ap
substrat
phosphat
sigmaaldrich
measur
absorb
nm
readout
perform
multiskan
rc
labsystem
helsinki
finland
use
genesi
softwar
cell
incub
psv
particl
per
cell
wash
pb
fix
paraformaldehyd
pfa
prepar
pb
min
room
temperatur
rt
egfr
co
stain
cell
fix
pfa
treat
triton
pb
min
rt
fix
cell
stain
use
primari
alexaconjug
secondari
antibodi
invitrogen
fluoresc
imag
perform
use
zeiss
axiovert
microscop
equip
planapochromat
na
axiovis
deconvolut
coloc
softwar
carl
zeiss
jena
germani
determin
amount
virus
coloc
either
egfr
hr
psv
exposur
use
randomli
chosen
rectangular
area
normal
assess
pixel
coloc
total
pixel
hacat
cell
transfect
specif
sirna
hr
either
left
nontreat
treat
solubl
egf
ngml
min
incub
psv
particl
per
cell
next
day
cell
fix
pfa
wash
pb
process
pla
et
al
use
duolink
situ
orang
starter
kit
mouserabbit
sigmaaldrich
briefli
fix
cell
incub
duolink
block
solut
hr
follow
stain
primari
antibodi
recogn
dissolv
duolink
antibodi
diluent
anoth
hr
next
sampl
wash
wash
buffer
prepar
accord
manufactur
recip
cell
incub
secondari
antibodi
conjug
dna
probe
dulink
antibodi
diluent
solut
anoth
hr
sampl
incub
ligat
solut
min
subsequ
sampl
incub
amplif
solut
contain
dna
polymeras
roll
circl
amplif
rca
min
final
sampl
wash
mount
duolink
situ
mount
media
dapi
signal
nm
analyz
zeiss
axiovert
microscop
equip
planapochromat
na
determin
pla
signal
normal
assess
pixel
pixel
record
dapi
hacat
cell
cultur
polyllysin
coat
glass
coverslip
cell
wash
follow
fixat
min
rt
pfa
pb
figur
incub
vge
psv
hr
wash
membran
sheet
gener
fix
figur
figur
cell
incub
min
psv
wash
fix
incub
hr
wash
fix
indic
use
cell
transfect
describ
control
sirna
mixtur
two
sirna
plasma
membran
sheet
gener
appli
ms
ultrasound
sonic
puls
essenti
describ
previous
homsi
et
al
differ
sever
puls
differ
coverslip
locat
appli
fixat
sampl
quench
mm
pb
min
sampl
permeabil
triton
pb
min
cell
membran
sheet
provid
access
epitop
present
membran
outer
leaflet
glass
coverslip
afterward
sampl
block
bsa
pb
min
sampl
incub
hr
whole
cell
overnight
membran
sheet
primari
antibodi
dilut
bsa
pb
employ
primari
antibodi
includ
mous
monoclon
see
rabbit
polyclon
see
rabbit
monoclon
see
egfr
afterward
sampl
wash
pb
incub
rt
secondari
antibodi
donkeyantirabbit
alexa
fluor
donkeyantimous
alexa
bsa
pb
hr
final
sampl
wash
mount
microscopi
slide
employ
prolong
gold
antifad
mountant
medium
invitrogen
twocolor
sted
micrograph
acquir
use
superresolut
sted
optic
modul
abberior
instrument
goettingen
germani
coupl
olympu
confoc
microscop
olympu
tokyo
japan
equip
uplansapo
na
object
olympu
tokyo
japan
avail
lime
imag
facil
twocolor
stedmicroscopi
realiz
sequenti
imag
two
channel
use
puls
nm
nm
laser
excit
alexa
respect
deplet
puls
nm
sted
laser
use
signal
emit
alexa
fluor
alexa
dye
detect
use
nm
filter
respect
depend
experi
pixel
size
set
nm
membran
sheet
nm
cell
imag
pinhol
size
set
imag
membran
sheet
focal
plane
adjust
slightli
membran
sheet
order
check
twodimension
structur
briefli
imag
possibl
membran
sheet
becom
immedi
unfocuss
focal
plane
displac
zaxi
wherea
cell
incomplet
gener
membran
sheet
still
show
structur
element
figur
supplement
imagej
region
interest
roi
select
far
channel
display
propag
respect
channel
pearson
correl
coeffici
pcc
two
channel
calcul
custom
imagej
macro
analyz
maxima
paramet
size
distanc
intens
custom
imagej
macro
use
macro
base
imagej
function
find
maxima
use
detect
cluster
viral
particl
give
posit
pixel
coordin
prior
maxima
detect
imag
smooth
gaussian
blur
reduc
fals
posit
maxima
due
nois
cluster
intens
calcul
center
five
pixel
diamet
circular
roi
onto
cluster
posit
cluster
intens
averag
cell
exact
cluster
psv
posit
determin
calcul
center
mass
fluoresc
within
circular
roi
use
analysi
maxima
low
mean
intens
au
depend
experi
channel
exclud
intens
measur
correct
local
background
measur
next
cell
psv
distanc
cluster
calcul
shortest
distanc
determin
case
found
psv
per
cell
therefor
psv
distanc
averag
one
condit
one
biolog
replic
roughli
cell
cluster
size
determin
appli
horizont
vertic
pixel
line
scan
center
cluster
posit
linescan
fit
gaussian
yield
full
width
half
maximum
correspond
cluster
size
depend
fit
qualiti
either
valu
horizont
vertic
line
scan
use
cluster
fit
rsquar
center
peak
exclud
cluster
size
valu
membran
sheet
averag
measur
level
perform
roi
use
cluster
size
analysi
intens
measur
correct
local
background
measur
next
membran
sheet
psv
accumul
track
use
find
maxima
function
imagej
determin
exact
object
posit
circular
roi
diamet
pixel
center
detect
maxima
center
mass
fluoresc
within
roi
measur
object
track
period
maxim
time
interv
frame
yield
x
yposit
object
time
meansquar
displac
msd
calcul
like
describ
previous
lang
et
al
plot
time
interv
msd
versu
time
plot
indic
unidirect
flow
ignor
determin
diffus
coeffici
fit
linear
regress
line
coeffici
calcul
singl
track
averag
diffus
coeffici
calcul
five
movi
record
tirf
microscopi
publish
describ
scheffer
et
al
analyz
detail
tirf
microscopi
see
scheffer
et
al
data
analysi
perform
use
statist
softwar
r
version
r
core
team
r
languag
environ
statist
comput
r
foundat
statist
comput
vienna
austria
valu
two
condit
compar
statist
assay
test
normal
use
shapirowilk
test
valu
follow
normal
distribut
p
test
homogen
varianc
use
bartlett
flignerkilleen
leven
test
sampl
consid
homoscedast
three
test
display
p
heteroscedast
one
display
differ
group
homoscedast
sampl
analyz
use
two
sampl
ttest
heteroscedast
welch
two
sampl
ttest
case
valu
follow
normal
distribut
wilcoxon
rank
sum
test
appli
exact
pvalu
given
statist
test
specif
sampl
state
bracket
fig
legend
statist
assay
appli
blot
graph
compar
control
n
present
analysi
state
fig
legend
denot
sampl
size
differ
group
consid
statist
signific
statist
signific
mark
graph
ns
signific
experi
repeat
independ
least
three
time
